Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.2M
-
Number of holders
-
281
-
Total 13F shares, excl. options
-
23M
-
Shares change
-
+336K
-
Total reported value, excl. options
-
$7.08B
-
Value change
-
+$149M
-
Put/Call ratio
-
0.93
-
Number of buys
-
146
-
Number of sells
-
-111
-
Price
-
$308.57
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q4 2024
358 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock as of Q4 2024.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) has 281 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23M shares
.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (2.21M shares), PAULSON & CO. INC. (2.04M shares), Avoro Capital Advisors LLC (2.03M shares), RTW INVESTMENTS, LP (1.99M shares), BAKER BROS. ADVISORS LP (1.97M shares), VANGUARD GROUP INC (1.71M shares), BlackRock, Inc. (1.49M shares), FMR LLC (868K shares), STATE STREET CORP (781K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (589K shares).
This table shows the top 281 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.